Try our Advanced Search for more refined results

Racies v. Quincy Bioscience, LLC

  1. May 04, 2020

    Prevagen Buyer Class Decertified After False Ad Suit Mistrial

    Following a mistrial, a California federal judge Monday decertified a class of consumers accusing a biotechnology company of falsely representing that its Prevagen supplement improves memory, finding that the named plaintiff equivocated at trial when asked about claims that had been key to certification.

  2. January 14, 2020

    Prevagen False Ad Case Ends In Mistrial After Jury Deadlocks

    A California federal judge declared a mistrial Tuesday after jurors said they were "hopelessly deadlocked" in deciding whether Prevagen maker Quincy Bioscience LLC misled consumers about the cognitive benefits of the popular dietary supplement.

  3. January 08, 2020

    Jury In False Ad Trial Told Memory-Boosting Pill Is A Lie

    A University of Toronto nutrition scientist professor testified Wednesday in a California federal jury trial over class claims alleging Quincy Bioscience LLC falsely advertised the cognitive benefits of Prevagen, saying the popular dietary supplement can't improve memory or promote clear thinking, because it can't cross the blood-brain barrier.

  4. December 18, 2017

    Prevagen Maker Must Face Certified Class In Labeling Suit

    A California federal judge on Friday certified a class of California consumers accusing a biotechnology company of falsely representing that its Prevagen supplement improves memory and supports brain function.

  5. October 16, 2017

    Prevagen Memory Product Maker Fights Cert. In Ad Suit

    The maker of dietary supplement Prevagen asked a California federal judge Monday to deny certification to a proposed multistate class of consumers who say the company falsely advertised the cognitive benefits of a jellyfish protein in a drug it markets as a memory booster.

  6. June 01, 2017

    JPML Won't Combine Suits Over Memory Booster Prevagen

    The Judicial Panel on Multidistrict Litigation has shot down a dietary supplement maker’s attempt to centralize four cases brought in New York, New Jersey and California accusing it of falsely advertising the cognitive benefits of a jellyfish protein in its memory booster Prevagen.